Companhia Brasileira de Distribuição (CBD) Stock Competitors & Peer Comparison
See (CBD) competitors and their performances in Stock Market.
Peer Comparison Table: Department Stores Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CBD | $0.45 | -3.05% | 218.1M | -14.83 | -$0.03 | N/A |
| DDS | $582.55 | -4.37% | 9.1B | 13.84 | $42.10 | +5.10% |
| M | $23.16 | +4.42% | 6.1B | 9.57 | $2.42 | +3.35% |
| JWN | $24.66 | +0.08% | 4.1B | 14.17 | $1.74 | N/A |
| PLBL | $6.08 | +16.36% | 2.2B | -304.00 | -$0.02 | N/A |
| KSS | $15.87 | -1.12% | 1.8B | 6.66 | $2.38 | +3.14% |
| EXTO | $3.61 | -0.55% | 585.7M | 90.25 | $0.04 | +2.66% |
| DDT | $26.07 | -0.21% | 412.1M | N/A | N/A | +7.16% |
Stock Comparison
CBD vs DDS Comparison June 2026
CBD plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBD stands at 218.1M. In comparison, DDS has a market cap of 9.1B. Regarding current trading prices, CBD is priced at $0.45, while DDS trades at $582.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBD currently has a P/E ratio of -14.83, whereas DDS's P/E ratio is 13.84. In terms of profitability, CBD's ROE is -0.54%, compared to DDS's ROE of +0.34%. Regarding short-term risk, CBD is less volatile compared to DDS. This indicates potentially lower risk in terms of short-term price fluctuations for CBD.Check DDS's competition here